Stay updated with breaking news from Primary Endpoint. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 12, 2023--
Oral presentation delivered at the American Heart Association (AHA) Scientific Sessions 2023 Analysis of clinical data shows statistically significant risk reductions in heart failure and separately in MACE related outcomes as early as approximately three months in patients at high risk for cardiovascular events INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Nov. 12, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today
Kodiak Sciences Inc. announced that data from tarcocimab tedromer will be presented during the annual meeting of the American Academy of Ophthalmology to be held November 3-6, 2023 in San Francisco....
NB: this is a summary translation of the press release original drafted in Japanese for the disclosure required in compliance...
Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company focused on rare diseases, announced Tuesday positive top-line results from the randomized withdrawal period of Study C602 of DCCR (Diazoxide Choline) for Prader-Willi syndrome or PWS.